Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants.
about
DNA Methylation Analysis: Choosing the Right MethodCracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and PerspectivesProtocol for assessing maternal, environmental and epigenetic risk factors for dental caries in childrenEpigenome data release: a participant-centered approach to privacy protectionSPlinted Ligation Adapter Tagging (SPLAT), a novel library preparation method for whole genome bisulphite sequencingGene, Environment and Methylation (GEM): a tool suite to efficiently navigate large scale epigenome wide association studies and integrate genotype and interaction between genotype and environment.The transcriptional landscape of age in human peripheral blood.Population whole-genome bisulfite sequencing across two tissues highlights the environment as the principal source of human methylome variation.Comparison of Methyl-capture Sequencing vs. Infinium 450K methylation array for methylome analysis in clinical samplesReflections on the Field of Human Genetics: A Call for Increased Disease Genetics TheoryThe genetic regulatory signature of type 2 diabetes in human skeletal muscle.Bisulfite oligonucleotide-capture sequencing for targeted base- and strand-specific absolute 5-methylcytosine quantitation.Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells.Increased DNA methylation variability in type 1 diabetes across three immune effector cell types.Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.Functional variation in allelic methylomes underscores a strong genetic contribution and reveals novel epigenetic alterations in the human epigenome.Comparative DNA methylation analysis to decipher common and cell type-specific patterns among multiple cell types.Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns.Targeted bisulfite sequencing of the dynamic DNA methylomeHigher chylomicron remnants and LDL particle numbers associate with CD36 SNPs and DNA methylation sites that reduce CD36.How to make DNA methylome wide association studies more powerfulRole of the TGF-β pathway in dedifferentiation of human mature adipocytes.Detection of prognostic methylation markers by methylC-capture sequencing in acute myeloid leukemia.Genome-wide identification of inter-individually variable DNA methylation sites improves the efficacy of epigenetic association studies.Targeted Bisulfite Sequencing Using the SeqCap Epi Enrichment System.Analysis of DNA modifications in aging research.BoostMe accurately predicts DNA methylation values in whole-genome bisulfite sequencing of multiple human tissues.Interactions between genetic variation and cellular environment in skeletal muscle gene expression.DNA methylation in the pathogenesis of type 2 diabetes in humans.
P2860
Q26769972-93B02BA6-43AF-403F-9D74-D5A7E6A9E3F9Q26776038-4A3D4985-9616-4D5C-AEAE-DCBA4D5AD4FDQ28397882-486441DB-0F53-4133-955A-5D095C90E984Q28646976-16CFB8F2-5EE8-4D92-9FB4-3E33A4D67931Q33557378-BCB5A88E-6EB8-4227-A6A6-158DB497F283Q36091905-71E84EC4-F9D9-464B-8461-FF88F2293129Q36265959-239D4C6C-873C-4522-8B00-1A4E0F3F08E9Q36424803-05CFD627-D1C6-40C5-8DFF-316A22C869DFQ36839015-AE900085-4EA9-4B60-AC64-B5AD4A426017Q36978721-6892B81A-DCC8-422E-B4ED-BCABD3AB4272Q37060991-15AC4695-C697-451A-9EEE-20C64E73AC56Q37219658-6D06E060-768D-441F-8C08-3DFCAB0A921DQ37429886-5A2C6FAA-7BA5-4750-8037-5E34BC72C54EQ37479109-A76D1B5A-C7CF-4AB0-8D56-81AAFB35A7B0Q37622957-0DCF6762-28A3-4205-8B12-E66F47502A43Q37682430-28621484-95D7-4594-BD2A-9BB063F8BA2FQ37694056-36775E65-7FC4-41DE-A26C-E626E88712F6Q38815614-01AB7B46-3D3E-4C40-B1D1-0076A488F664Q38816602-732BA001-8774-4C76-A5BF-A050690ACF55Q39003554-A5178125-737B-4267-B840-892EC17644C3Q39096666-7B930155-5136-47D4-AA6E-E675E9D8B5CAQ40545995-B31E49D3-1A8A-4285-B926-8000B92BF17FQ40813909-AC8EB138-3A87-4C87-97C1-A237049CF544Q41190490-E4107595-ED7D-42C7-9032-C71DDD1E0459Q47094866-FC9BB058-AE87-47BB-80C3-E19FA0C88C9FQ47150465-6DB4ECB9-7E5E-4CAB-A4FF-7FCB482744AAQ47336530-8DA17091-4D5B-4A05-9D52-35BF6FC5D905Q54972965-D09EBF9F-7291-4DBA-981C-B55A0A9A22ABQ55105895-191F6272-0889-4236-B16C-68FDD44122BDQ55263060-A3CD4B4E-6457-4B0E-84A6-F6A7858F7D17Q55496885-602076ED-949E-4441-8137-B154148AE590
P2860
Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Characterization of functional ...... l disease-associated variants.
@ast
Characterization of functional ...... l disease-associated variants.
@en
type
label
Characterization of functional ...... l disease-associated variants.
@ast
Characterization of functional ...... l disease-associated variants.
@en
prefLabel
Characterization of functional ...... l disease-associated variants.
@ast
Characterization of functional ...... l disease-associated variants.
@en
P2093
P2860
P50
P356
P1476
Characterization of functional ...... l disease-associated variants.
@en
P2093
André Tchernof
Daniel Burgess
Elin Grundberg
Fiona Allum
Frédéric Guénard
Julie Lessard
Karolina Tandre
Lars Rönnblom
Marie-Michelle Simon
P2860
P2888
P356
10.1038/NCOMMS8211
P407
P577
2015-05-29T00:00:00Z
P5875
P698
P818
1502.05413